Related Experiment Video
Updated: Jul 12, 2025
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Evidence-based clinical practice guideline for management of urinary tract infection and primary vesicoureteric
Pankaj Hari1, Jitendra Meena2, Manish Kumar3
1Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India. pankajhari@hotmail.com.
Insights
Updated guidelines for childhood urinary tract infection (UTI) and primary vesicoureteric reflux (VUR) management are presented. Key points include diagnostic criteria, treatment durations, and indications for imaging and antibiotic prophylaxis in pediatric nephrology.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Clinical Practice Guidelines
Background:
- Urinary tract infections (UTIs) and primary vesicoureteric reflux (VUR) are common in children.
- Standardized, evidence-based guidelines are crucial for optimal management.
- Previous guidelines may not reflect the latest evidence or international standards.
Purpose of the Study:
- To present updated, evidence-based clinical practice guidelines for pediatric UTI and VUR management.
- To ensure guidelines conform to international standards using rigorous development methodology.
- To provide clear recommendations and clinical practice points for healthcare professionals globally.
Main Methods:
- Guidelines developed by the Indian Society of Pediatric Nephrology (ISPN) using Institute of Medicine and AGREE checklists.
- Systematic review of evidence to formulate recommendations and clinical practice points.
- Seventeen recommendations and 18 clinical practice points formulated for UTI and VUR management.
Main Results:
- Significant UTI diagnosis in infants requires urine culture >10^4 CFU/mL with strong clinical suspicion.
- Urine leukocyte esterase and nitrite tests can screen for UTI, replacing microscopy.
- Oral antibiotics for 7-10 days are suitable for non-toxic infants with acute pyelonephritis.
- Acute-phase DMSA scans are not recommended for UTI evaluation.
- Micturating cystourethrography (MCU) indicated for recurrent UTI, abnormal kidney ultrasound, or non-E. coli UTI in children <2 years.
- DMSA scan indicated for recurrent UTI and high-grade VUR (3-5).
- Antibiotic prophylaxis not recommended for children with normal urinary tracts post-UTI.
- Prophylaxis recommended for children with bladder bowel dysfunction (BBD) and high-grade VUR.
- Prophylaxis can cease in VUR patients who are toilet-trained, BBD-free, and UTI-free for 1 year.
- Surgery for high-grade VUR considered for parental preference or recurrent febrile UTIs on prophylaxis.
Conclusions:
- These globally applicable guidelines provide a robust framework for managing pediatric UTI and VUR.
- The guidelines emphasize judicious use of diagnostic imaging and antibiotic prophylaxis.
- Recommendations aim to optimize treatment outcomes and minimize unnecessary interventions in children.
Abstract:
We present updated, evidence-based clinical practice guidelines from the Indian Society of Pediatric Nephrology (ISPN) for the management of urinary tract infection (UTI) and primary vesicoureteric reflux (VUR) in children. These guidelines conform to international standards; Institute of Medicine and AGREE checklists were used to ensure transparency, rigor, and thoroughness in the guideline development. In view of the robust methodology, these guidelines are applicable globally for the management of UTI and VUR. Seventeen recommendations and 18 clinical practice points have been formulated. Some of the key recommendations and practice points are as follows. Urine culture with > 104 colony forming units/mL is considered significant for the diagnosis of UTI in an infant if the clinical suspicion is strong. Urine leukocyte esterase and nitrite can be used as an alternative screening test to urine microscopy in a child with suspected UTI. Acute pyelonephritis can be treated with oral antibiotics in a non-toxic infant for 7-10 days. An acute-phase DMSA scan is not recommended in the evaluation of UTI. Micturating cystourethrography (MCU) is indicated in children with recurrent UTI, abnormal kidney ultrasound, and in patients below 2 years of age with non-E. coli UTI. Dimercaptosuccinic acid scan (DMSA scan) is indicated only in children with recurrent UTI and high-grade (3-5) VUR. Antibiotic prophylaxis is not indicated in children with a normal urinary tract after UTI. Prophylaxis is recommended to prevent UTI in children with bladder bowel dysfunction (BBD) and those with high-grade VUR. In children with VUR, prophylaxis should be stopped if the child is toilet trained, free of BBD, and has not had a UTI in the last 1 year. Surgical intervention in high-grade VUR can be considered for parental preference over antibiotic prophylaxis or in children developing recurrent breakthrough febrile UTIs on antibiotic prophylaxis.
Related Concept Videos
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
01:17Urinary Tract Infection IV: Nursing Management
01:28Urinary Tract Calculi V: Nursing Management
01:30Urinary Tract Calculi III: Medical Management
01:22Imaging Studies V: Intravenous Urography and Retrograde Pyelography
01:28Acute Pyelonephritis II: Diagnostic Studies and Management